Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Earth Science Tech ( (ETST) ) just unveiled an announcement.
On July 1, 2025, Earth Science Tech, Inc. announced its qualification for and listing on the newly launched OTCID tier of the OTC Markets, reflecting its commitment to enhanced disclosure, transparency, and compliance standards. This achievement is expected to boost investor confidence, attract new stakeholders, and support the company’s strategic growth initiatives, marking a significant turnaround for the company over the past two years.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
Earth Science Tech exhibits strong financial performance with substantial revenue growth and high returns on equity, bolstered by effective cost management and cash flow generation. Technically, the stock shows moderate momentum, but key averages suggest caution. Valuation is fair, with potential for growth reinvestment, though the absence of a dividend limits appeal to income investors. These factors collectively support a positive, albeit cautious, outlook for the stock.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company’s operations span compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries, including RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.
Average Trading Volume: 65,485
Technical Sentiment Signal: Buy
Current Market Cap: $56.51M
For an in-depth examination of ETST stock, go to TipRanks’ Overview page.